Description: The Center regulates a variety of biological therapeutic products, as diverse as blood and blood components; antitoxins; proteins generated by hybridoma or recombinant DNA technology; products that consist of manipulated, cultured, or expanded human cells; vaccines directed against non-infectious disease targets; and gene transfer products.